Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada flag Canada · Delayed Price · Currency is CAD
7.20
-0.13 (-1.77%)
Aug 25, 2025, 4:00 PM EDT

Eupraxia Pharmaceuticals Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
2591611477935-
Upgrade
Market Cap Growth
125.43%9.66%85.89%125.87%--
Upgrade
Enterprise Value
2731471275810-
Upgrade
Last Close Price
7.204.515.373.652.45-
Upgrade
PB Ratio
9.053.51124.328.081.83-
Upgrade
P/TBV Ratio
-65.7050.067.481.75-
Upgrade
Debt / Equity Ratio
0.000.0011.711.250.52-0.59
Upgrade
Quick Ratio
7.6010.741.016.0013.380.03
Upgrade
Current Ratio
8.7211.101.026.0813.490.05
Upgrade
Return on Equity (ROE)
-169.25%-157.31%-715.19%-178.04%--
Upgrade
Return on Assets (ROA)
-75.00%-61.14%-88.37%-52.20%-68.51%-59.25%
Upgrade
Return on Capital (ROIC)
-93.38%-78.03%-126.40%-58.41%-110.75%-
Upgrade
Earnings Yield
-15.48%-22.84%-25.44%-31.75%-68.66%-
Upgrade
FCF Yield
-16.28%-26.96%-18.77%-25.12%-43.73%-
Upgrade
Buyback Yield / Dilution
-21.81%-40.52%-25.21%-55.45%-102.75%-0.01%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.